Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018)

Updated

Analysis

Artelo Biosciences (ARTL) Capital Expenditures (2017 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Aug 31, 2018 -42.00
Feb 28, 2018 20.00
Nov 30, 2017 867.00
API Access

Artelo Biosciences Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ARTL&period=max&api_key=YOUR_API_KEY